Back
ProShares UltraShort Bloomberg Crude Oil Vs. Akero Therapeutics Industry Stock Comparison
Sell
28
SCO
ProShares UltraShort Bloomberg Crude Oil
Last Price:
$16.76
Seasonality Move:
-6.48%
Sell
42
AKRO
Akero Therapeutics
Last Price:
$52.10
Seasonality Move:
25.71%
Sell
28
ProShares UltraShort Bloomberg Crude Oil (SCO)
is a Sell
Is ProShares UltraShort Bloomberg Crude Oil a Buy, Sell or Hold?
-
The current ProShares UltraShort Bloomberg Crude Oil [SCO] share price is $16.75. The Score for SCO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
SCO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $52.08. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCO Stock Price Chart
What is ProShares UltraShort Bloomberg Crude Oil's stock price today?
-
The ProShares UltraShort Bloomberg Crude Oil share price today is $16.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.08The current trend is moderately bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
SCO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.68 | Buy |
Relative Strength Index (14 RSI): | 43.8 | Sell |
Chaikin Money Flow: | 2143534 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.97 - 17.79) | Sell |
Bollinger Bands (100): | (17.05 - 20.65) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 49.78 | Sell |
Chaikin Money Flow: | -771778 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.65 - 55.11) | Sell |
Bollinger Bands (100): | (40.15 - 52.25) | Buy |
SCO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.85 | Sell |
20-day SMA: | 17.11 | Sell |
50-day SMA: | 18.36 | Sell |
200-day SMA: | 18.06 | Sell |
8-day EMA: | 15.08 | Buy |
20-day EMA: | 9.99 | Buy |
50-day EMA: | 5.09 | Buy |
200-day EMA: | 1.45 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.4 | Sell |
20-day SMA: | 52.96 | Sell |
50-day SMA: | 50.04 | Buy |
200-day SMA: | 39.84 | Buy |
8-day EMA: | 52.64 | Sell |
20-day EMA: | 52.51 | Sell |
50-day EMA: | 50.35 | Buy |
200-day EMA: | 41.57 | Buy |
ProShares UltraShort Bloomberg Crude Oil Earnings Growth & SCO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.64 per share.
ProShares UltraShort Bloomberg Crude Oil Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |